Canlyniadau Chwilio - Oomen‑deHoop, Esther

Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase Inhibitors gan van Eerden, Ruben A. G., Oomen-de Hoop, Esther, Noordam, Aad, Mathijssen, Ron H. J., Koolen, Stijn L. W.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Locoregional control and survival after lymph node SBRT in oligometastatic disease gan Loi, Mauro, Frelinghuysen, Michael, Klass, Natalie Desiree, Oomen-De Hoop, Esther, Granton, Patrick Vincent, Aerts, Joachim, Verhoef, Cornelis, Nuyttens, Joost

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Scopolaminebutyl given prophylactically for death rattle: study protocol of a randomized double-blind placebo-controlled trial in a frail patient population (the SILENCE study) gan van Esch, Harriëtte J., van Zuylen, Lia, Oomen–de Hoop, Esther, van der Heide, Agnes, van der Rijt, Carin C. D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients gan Mendelaar, Pauline A. J., Kraan, Jaco, Van, Mai, Zeune, Leonie L., Terstappen, Leon W. M. M., Oomen‐de Hoop, Esther, Martens, John W. M., Sleijfer, Stefan

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients gan de Man, Femke M., van Eerden, Ruben A.G., Oomen-de Hoop, Esther, Veraart, Joris N., van Doorn, Nadia, van Doorn, Leni, van der Gaast, Ate, Mathijssen, Ron H.J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl gan Kuip, Evelien J.M., Oldenmenger, Wendy H., Visser-Thijs, Martine F., de Bruijn, Peter, Oomen-de Hoop, Esther, Mathijssen, Ron H.J., Van der Rijt, Carin C.D., Koolen, Stijn W.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life: The SILENCE Randomized Clinical Trial gan van Esch, Harriëtte J., van Zuylen, Lia, Geijteman, Eric C. T., Oomen-de Hoop, Esther, Huisman, Bregje A. A., Noordzij-Nooteboom, Heike S., Boogaard, Renske, van der Heide, Agnes, van der Rijt, Carin C. D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer gan Kuip, Evelien J. M., Oldenmenger, Wendy H., Thijs—Visser, Martine F., de Bruijn, Peter, Oosten, Astrid W., Oomen—de Hoop, Esther, Koolen, Stijn L. W., Van der Rijt, Carin C. D., Mathijssen, Ron H. J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study gan van der Louw, Elles J. T. M., Olieman, Joanne F., van den Bemt, Patricia M. L. A., Bromberg, Jacoline E. C., Oomen-de Hoop, Esther, Neuteboom, Rinze F., Catsman-Berrevoets, Coriene E., Vincent, Arnaud J. P. E.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients gan Agema, Bram C., Koolen, Stijn L.W., de With, Mirjam, van Doorn, Nadia, Heersche, Niels, Oomen-de Hoop, Esther, Visser, Sabine, Aerts, Joachim G.J.V., Bins, Sander, van Schaik, Ron H.N., Mathijssen, Ron H.J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The added value of H(2) antagonists in premedication regimens during paclitaxel treatment gan Cox, Juul M., van Doorn, Leni, Malmberg, Ruben, Oomen-de Hoop, Esther, Bosch, Tessa M., van den Bemt, Patricia M. L. A., Boere, Ingrid A., Jager, Agnes, Mathijssen, Ron H. J., van Leeuwen, Roelof W. F.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms gan van Dessel, Lisanne F., Vitale, Silvia R., Helmijr, Jean C. A., Wilting, Saskia M., van der Vlugt‐Daane, Michelle, Oomen‐de Hoop, Esther, Sleijfer, Stefan, Martens, John W. M., Jansen, Maurice P. H. M., Lolkema, Martijn P.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy gan Kuip, Evelien J. M., Oldenmenger, Wendy H., Oomen-de Hoop, Esther, Verduijn, Gerda M., Thijs-Visser, Martine F., de Bruijn, Peter, van Meerten, Esther, Koolen, Stijn L. W., Mathijssen, Ron H. J., van der Rijt, Carin C. D.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Association between Paclitaxel Clearance and Tumor Response in Patients with Esophageal Cancer gan Toxopeus, Eelke L.A., de Man, Femke M., Krak, Nanda, Biermann, Katharina, Nieuweboer, Annemieke J.M., Friberg, Lena E., Oomen-de Hoop, Esther, van Lanschot, Jan J.B., Shapiro, Joel, Wijnhoven, Bas P.L., Mathijssen, Ron H.J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine gan de Man, Femke M., Veerman, G.D. Marijn, Oomen-de Hoop, Esther, Deenen, Maarten J., Meulendijks, Didier, Mandigers, Caroline M.P.W., Soesan, Marcel, Schellens, Jan H.M., van Meerten, Esther, van Gelder, Teun, Mathijssen, Ron H.J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors gan Hussaarts, Koen G. A. M., Berger, Florine A., Binkhorst, Lisette, Oomen - de Hoop, Esther, van Leeuwen, Roelof W. F., van Alphen, Robbert J., Mathijssen - van Stein, Daniëlle, de Groot, Natasja M. S., Mathijssen, Ron H. J., van Gelder, Teun

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634 gan Atrafi, Florence, van Eerden, Ruben A. G., Koolen, Stijn L. W., de Bruijn, Peter, Rijcken, Cristianne J. F., Hanssen, Rob, Eskens, Ferry A. L. M., Lolkema, Martijn P., Oomen-de Hoop, Esther, Damman, Jeffrey, Mathijssen, Ron H. J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy gan de With, Mirjam, Hurkmans, Daan P., Oomen-de Hoop, Esther, Lalouti, Ayoub, Bins, Sander, El Bouazzaoui, Samira, van Brakel, Mandy, Debets, Reno, Aerts, Joachim G. J. V., van Schaik, Ron H. N., Mathijssen, Ron H. J., van der Veldt, Astrid A. M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Decisional Conflict after Deciding on Potential Participation in Early Phase Clinical Cancer Trials: Dependent on Global Health Status, Satisfaction with Communication, and Timing gan van Lent, Liza G. G., de Jonge, Maja J. A., van der Ham, Mirte, van Mil, Marjolein, Gort, Eelke H., Hasselaar, Jeroen, Oomen-de Hoop, Esther, van der Rijt, Carin C. D., van Weert, Julia C. M., Lolkema, Martijn P.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug–drug interaction study gan Belderbos, Bodine P.S., Hussaarts, Koen G.A.M., van Harten, Leonie J., Oomen‐de Hoop, Esther, de Bruijn, Peter, Hamberg, Paul, van Alphen, Robbert J., Haberkorn, Brigitte C.M., Lolkema, Martijn P., de Wit, Ronald, van Soest, Robert J., Mathijssen, Ron H.J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn